STAT3 and benign prostatic hyperplasia: As shown in Fig. 7, the positive expression level of phosphorylated STAT3 (p-STAT3) in the model group was markedly increased compared with that in the normal group (P<0.05), but treatment with finasteride or QC significantly inhibited the effect of BPH model construction on the STAT3 phosphorylation.